SAN FRANCISCO, October 22, 2026--Warp Sciences today emerged from stealth with $215 million in funding to create the infrastructure that enables biotech and pharmaceutical companies to discover new medicines faster. The company is building a U.S.-based chemistry contract research organization (CRO) that brings expert chemists, AI, and robotics together to make and test the molecules research teams need. Its ambition is to make discovery compound: experimental data helps train better AI, better A